Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) fair value: what the stock is really worth
As of Oct 28, 2026: fair value (intrinsic value) of Shin Nippon Biomedical Laboratories, Ltd. stock $10.53, price $9.16, upside +14.9%, quality 46 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Shin Nippon Biomedical Laboratories, Ltd.
SBLOF · USRising price, but only slightly cheap (13% below fair value) and weak company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
42‑month range $8.37 – $14.93 · fair‑value band $5.88 – $14.64 · the $9.16 price screens below the $10.53 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Shin Nippon Biomedical Laboratories is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.
Show moreShow less
It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies.
The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels.
In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.
Stock analysis
Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) currently trades at $9.16, while our model-based Fair Value estimate is $10.53, implying the stock looks roughly 13% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $12.88 per share, and 12 of the 26 models we run sit above the $9.16 price.
Bear case: the Dividend Discount group reads lowest at $4.10, and 14 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: $5.88 (bear) to $14.64 (bull), the price of $9.16 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Shin Nippon Biomedical Laboratories, Ltd. reported revenue of ¥32.5B in FY2026 versus ¥17.7B in FY2022, a compound +16.3%/yr. Reported net income was ¥4.6B in FY2026, compounding −10.5%/yr from FY2022.
Key figures
Market cap $381M Small · P/E ratio 12.5 · P/S ratio 1.76 · EPS (TTM) $0.7300 · Dividend yield 3.4% · Net margin 14.0% · Return on equity 13.7% · Return on assets (EBIT) 6.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 6% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at 15%, SBLOF screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch SBLOF, get fair value alerts →
Compare Shin Nippon Biomedical Laboratories, Ltd. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 151 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- PEG screener for stocks with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Illumina, Inc ILMN | $198.00 | $227.71 | +15% | vs SBLOF |
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs SBLOF |
| IQVIA Holdings IQV | $264.73 | $291.63 | +10% | vs SBLOF |
| Thermo Fisher Scientific Inc TMO | $691.33 | $686.04 | −1% | vs SBLOF |
| Danaher Corporation DHR | $229.91 | $209.18 | −9% | vs SBLOF |
| IDEXX Laboratories, Inc IDXX | $700.65 | $496.48 | −29% | vs SBLOF |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs SBLOF |
| Mettler-Toledo International Inc MTD | $1,727 | $655.06 | −62% | vs SBLOF |
| Agilent Technologies, Inc A | $172.92 | $64.20 | −63% | vs SBLOF |
| Waters Corporation WAT | $453.42 | $91.26 | −80% | vs SBLOF |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) overvalued or undervalued?
What is the fair value of SBLOF?
What is the quality score of SBLOF?
What is the price target for Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the Shin Nippon Biomedical Laboratories, Ltd. stock forecast for 2026?
What is the revenue of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
Does Shin Nippon Biomedical Laboratories, Ltd. pay a dividend?
How much is the dividend of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) and when is the ex-dividend date?
What growth is priced into Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What discount rate (WACC) does the fair value of SBLOF use?
What is a reverse DCF?
How much growth has Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) delivered so far?
How fast is the sector of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) growing?
What is the free cash flow yield of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the intrinsic value of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
Is Shin Nippon Biomedical Laboratories, Ltd. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SBLOF?
How much is Shin Nippon Biomedical Laboratories, Ltd. worth?
What do the bullish and bearish scenarios say about SBLOF?
What is the P/E ratio of SBLOF?
How solid is the balance sheet of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
How far is SBLOF from its 52-week high?
Which stocks are comparable to Shin Nippon Biomedical Laboratories, Ltd.?
Is Shin Nippon Biomedical Laboratories, Ltd. stock attractive at the current price?
How is the fair value of SBLOF calculated?
Is it still worth investing in stocks now?
What is the share price of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What should I pay attention to with Shin Nippon Biomedical Laboratories, Ltd. right now?
Key figures of Shin Nippon Biomedical Laboratories, Ltd.
How large is the market capitalisation of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the P/S ratio of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What are the earnings per share of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the dividend yield of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the net margin of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the return on equity of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the EBIT return on assets of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
What is the operating margin of Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
How fast is revenue growing at Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
How fast are earnings growing at Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)?
How much net debt does Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) carry?
Watch Shin Nippon Biomedical Laboratories, Ltd. in the live analysis
One click puts Shin Nippon Biomedical Laboratories, Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.